Abstract
Several epidemiological studies have associated the presence of hepatitis C virus (HCV) with the development of B-cell malignant lymphoma. However, in areas where the prevalence of HCV is low, this association has not been demonstrated. The aim of this study was to established the prevalence of HCV in patients with B-cell malignant lymphoma. The study was performed in 416 patients with new, previously untreated B-cell malignant lymphoma (236 diffuse large cell [DLC], 97 follicular lymphoma, and 83 marginal B-cell zone malignant lymphoma) and 1902 cases (682 first-degree relatives, 832 healthy blood donors, and 408 patients with solid tumors); furthermore, 353 patients with chronic liver disease associated to HCV were the control groups.
We found a prevalence of 0.48 positive HCV among malignant lymphoma, 0.12 for healthy blood donors, 0 in first-degree relatives, and 0.56 in patients with solid tumors, that were statistically significant. The odds ratio was 1.86 and its confidence interval included the equality. None of the patients with chronic liver disease and HCV developed malignant lymphoma in a median follow-up of 7.9 yr. We felt that the presence of HCV is not significant in the development of malignant lymphoma, and that reports of high prevalence were associated also to a high prevalence of HCV in the general population and this association will be considered hazardous.
Similar content being viewed by others
References
Ferri, C., et al. (1994). Hepatitis C virus infection in patients with non-Hodgkin’s lymphoma. Br. J. Haematol. 88:392–394.
Vallisa, D., et al. (1999). Association between hepatitis C virus and non-Hodgkin’s lymphoma and effects on viral infection on histologic subtype and clinical course. Am. J. Med. 106:556–560.
Zuckerman, E., et al. (1997). Hepatitis C virus infection in patients with B-cell non-Hodgkin’s lymphoma. Ann. Intern. Med. 127:423–428.
Zucca, E., et al. (2000). Prevalence of Helicobacter pylori and hepatitis C virus among non-Hodgkin’s lymphoma patients in southern Switzerland. Haematologica 85:147–153.
Kim, J.H., et al. (2000). A case of primary hepatic lymphoma with hepatitis C virus cirrhosis. Am. J. Gastroenterol. 95:2377–2380.
Franzin, F., et al. (1995). Clonal B-cell expansions in peripheral blood of HCV infected patients. Br. J. Haematol. 90:548–552.
Quinn, E.R., et al. (2001). The B-cell receptor of a hepatitis C virus associated non-Hodgkin’s lymphoma a binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 98:3745–3749.
Arican, A., et al. (2000). Prevalence of hepatitis C virus and hepatitis chronic infection in patients with non-Hodgkin’s lymphoma. Med. Oncol. 17:123–126.
Germanidis, G., et al. (1999). Hepatitis C virus infection in patients with overt B-cell non-Hodgkin’s lymphoma in a French center. Blood 93:1778–1779.
Piotelli, P., et al. (2000). Hepatitis C virus and non-Hodgkin’s lymphoma. A reappraisal after a prospective case control study of 300 patients. Am. J. Hematol. 64:95–100.
Panuska, I., et al. (2000). Low prevalence of chronic hepatitis C virus infection in B-cell non-Hodgkin’s lymphoma patients from a population with high prevalence of healthy hepatitis C virus carriers. [letter]. Br. J. Haematol. 109:248–249.
Pozzano, G., et al. (1998). Ethnic differences in the prevalence of mononuclear B-cell proliferation in patients affected by hepatitis C virus chronic liver disease. J. Hepatol. 30:990–994.
Collier, J.D., et al. (1999). No association between hepatitis C and B-cell lymphoma. Hepatology 29:1259–1261.
Zuckerman, E., et al. (1998). Dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematological malignancies. Cancer 83:1224–1230.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Avilés, A., Valdez, L., Halabe, J. et al. No association between lymphoma and hepatitis C virus. Med Oncol 20, 165–168 (2003). https://doi.org/10.1385/MO:20:2:165
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/MO:20:2:165